GlassScriptPhysician profile
Colm Joseph Murphy
NPI 1881291979
$6,012.41
in general payments reported to CMS, 2019-2025
14 companies · $823 in 2025
The $823 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $1,315 · 2023: $173 · 2024: $3,496 · 2025: $823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,595 · Food and Beverage: $1,898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,594.81 |
| Food and Beverage | $1,897.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,991.13 | 2021-2024 | Advisa Dr Mri Surescan, Azure Xt Dr Mri Surescan, Symplicity G3 |
| Shockwave Medical, INC | $506.89 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $332.31 | 2022-2025 | Impella |
| Novo Nordisk INC | $250.00 | 2023-2025 | Ozempic |
| Boston Scientific Corporation | $218.32 | 2024-2025 | General - Therapies, Eluvia, Rotapro |
| Merck Sharp & Dohme LLC | $149.69 | 2022-2025 | Verquvo |
| Chiesi USA, INC. | $109.37 | 2024-2025 | Kengreal |
| Amgen INC. | $96.23 | 2024-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.62 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $83.63 | 2022-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $76.80 | 2022 | |
| Novartis Pharmaceuticals Corporation | $72.11 | 2023-2025 | |
| Heartflow, INC. | $17.84 | 2025 | |
| Cordis US Corp. | $17.47 | 2025 | Mynx Control Venous |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colm Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.